KPV (10mg)
Especificaciones técnicas
| Pureza (HPLC) | ≥98% (HPLC) |
| Número CAS | 67727-97-3 |
| Forma | White lyophilized powder |
| Almacenamiento | -20°C |
| Secuencia | Lys-Pro-Val |
| Peso molecular | 342.43 g/mol |
| Forma salina | Acetate |
| Solubilidad | Soluble in water |
KPV (10mg)
Precio de lista en EUR · HU, SK, CZ, PL
- Eurozone (EUR)87,00 EUR
- Hungría (HU)87,00 EUR≈ 34 800 Ft
- Eslovaquia (SK)87,00 EUR
- Chequia (CZ)87,00 EUR≈ 2 175 Kč
- Polonia (PL)87,00 EUR≈ 369,75 zł
Mismo precio de lista en EUR para envío a Hungría, Eslovaquia, República Checa y Polonia. El pago se cobra en EUR.
HUF/CZK/PLN indicativos convertidos desde EUR; Eslovaquia usa EUR. Tasas aproximadas. Cobro en EUR.
Alpha-MSH C-terminal tripeptide for inflammation research.
Mechanism: Inhibits NF-κB, reduces TNF-α/IL-1β/IL-6, penetrates cell membranes.
Applications: IBD models, wound healing, gut-immune research.
Note: No pigmentation effects unlike full α-MSH.
Estrictamente para investigación de laboratorio.
No apto para consumo humano, uso veterinario ni diagnóstico.
From the Peptide Explorer
A tripeptide derived from the C-terminal end of alpha-MSH. Unlike the parent molecule, KPV lacks melanocortin receptor binding but retains potent anti-inflammatory signaling, making it a focus of GI and dermatological research.
Key Mechanisms
- ›NF-κB inhibition (independent of MC receptors)
- ›Intracellular PEP-T1 transporter uptake
- ›Inflammatory cytokine suppression (TNF-α, IL-6, IL-1β)
- ›Direct antimicrobial activity
Primary Research Areas
- ›Inflammatory bowel conditions
- ›Dermatitis
- ›Antimicrobial defense
- ›Mucosal healing
Key Research Findings
- Reduced colonic inflammation in DSS-colitis mouse model (Dalmasso et al., 2008)
- Exhibited direct antimicrobial activity against S. aureus and C. albicans
- Transported into intestinal epithelial cells via PEP-T1 transporter
Research Overview
A tripeptide derived from the C-terminal end of alpha-MSH. Unlike the parent molecule, KPV lacks melanocortin receptor binding but retains potent anti-inflammatory signaling, making it a focus of GI and dermatological research.
Origin: C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH)
Mechanism of Action
- NF-κB inhibition (independent of MC receptors)
- Intracellular PEP-T1 transporter uptake
- Inflammatory cytokine suppression (TNF-α, IL-6, IL-1β)
- Direct antimicrobial activity
Primary Research Areas
- Inflammatory bowel conditions
- Dermatitis
- Antimicrobial defense
- Mucosal healing
Key Published Findings
- Reduced colonic inflammation in DSS-colitis mouse model (Dalmasso et al., 2008)
- Exhibited direct antimicrobial activity against S. aureus and C. albicans
- Transported into intestinal epithelial cells via PEP-T1 transporter
Research Protocol
Commonly studied routes: Oral, Topical, Subcutaneous. Reconstitute with bacteriostatic water. Consult published literature for dose ranges; use our Peptide Calculator for volumetric preparation.
Storage
-20°C lyophilized, 2-8°C reconstituted
Important Notice
KPV (10mg) is supplied for laboratory research use only (RUO). Not for human or veterinary use, diagnostics, or therapeutics.
Especificaciones de investigación
Synthesized for strict analytical consistency. Verified via HPLC/MS.Ver estándares de calidad →
Manipulación y almacenamiento
- Store lyophilized at -20°C
- Protect from light and moisture
- Use sterile bacteriostatic water for reconstitution
- Minimize freeze-thaw cycles
- Solubility: Soluble in water
Preguntas frecuentes
What is KPV (10mg)?▼
Is KPV (10mg) intended for human consumption?▼
How do you verify purity and identity?▼
How should KPV (10mg) be stored?▼
Do you provide a Certificate of Analysis (COA)?▼
What purity is KPV (10mg)?▼
Verified Research Reviews
Fani
"best product for inflammation "